They recently discovered that disabling a lung cancer gene called NRF2 using CRISPR gene editing allows chemotherapy to work better to target cancer cells. The Gene Editing Institute, working with its ...
The work presented will be of interest to cancer biologists and more broadly to those interested in NSCLC translational studies. Non-small cell lung cancer (NSCLC) is the most common subtype of lung ...